AN ALTERNATIVELY-SPLICED MESSENGER-RNA IN THE CARBOXY-TERMINUS OF THE NEUROFIBROMATOSIS TYPE-1 (NF1) GENE IS EXPRESSED IN MUSCLE

被引:0
|
作者
GUTMANN, DH
ANDERSEN, LB
COLE, JL
SWAROOP, M
COLLINS, FS
机构
[1] UNIV MICHIGAN,SCH MED,DEPT NEUROL,4570 MED SCI RES BLDG 2,BOX 0650,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109
[3] UNIV MICHIGAN,SCH MED,DEPT GENET,ANN ARBOR,MI 48109
[4] UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gene for neurofibromatosis type 1 (NF1) was identified by positional cloning and found to contain two alternatively spliced exons. The first described alternatively spliced exon (exon 23a) is located within the GAP-related domain of the gene and inserts an additional 63 nucleotides into the NF1 mRNA. The second alternatively spliced exon (exon 48a) is located near the extreme carboxy terminus of the gene and inserts an additional 54 nucleotides into the mRNA. This second isoform, termed 3'ALT, was originally detected while screening a fetal brain cDNA library. Examination of its expression by reverse-transcribed RNA PCR demonstrates high level of expression in cardiac muscle, skeletal muscle and smooth muscle. Trace levels of expression are detected in brain and nerve. The 3'ALT isoform is expressed in fetal cardiac muscle, adult left ventricle and cardiac Purkinje cells. Further confirmation of the existence of this isoform was obtained by blotting the PCR products with a radiolabeled oligonucleotide entirely derived from sequences contained within exon 48a and by direct sequencing of the PCR products. Additionally, this isoform is expressed in muscle tissues from other vertebrate species. The expression of this isoform in muscle suggests that the NF1 gene may play additional tissue-specific roles in muscle development and signal transduction.
引用
收藏
页码:989 / 992
页数:4
相关论文
共 50 条
  • [1] THE NEUROFIBROMATOSIS TYPE-1 GENE (NF1) AND ITS PRODUCT
    HOVNANIAN, A
    LAPLANCHE, JL
    VIDAUD, M
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1992, 119 (05): : 385 - 389
  • [2] A DELETION IN THE 5'-REGION OF THE NEUROFIBROMATOSIS TYPE-1 (NF1) GENE
    HOFFMEYER, S
    ASSUM, G
    KAUFMANN, D
    SCHWENK, K
    KRONE, W
    HUMAN GENETICS, 1994, 94 (01) : 97 - 100
  • [3] CHARACTERIZATION OF GERMLINE MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-1 (NF1) GENE
    UPADHYAYA, M
    MAYNARD, J
    OSBORN, M
    HUSON, SM
    PONDER, M
    PONDER, BAJ
    HARPER, PS
    JOURNAL OF MEDICAL GENETICS, 1995, 32 (09) : 706 - 710
  • [4] BENIGN NEUROFIBROMAS IN TYPE-1 NEUROFIBROMATOSIS (NF1) SHOW SOMATIC DELETIONS OF THE NF1 GENE
    COLMAN, SD
    WILLIAMS, CA
    WALLACE, MR
    NATURE GENETICS, 1995, 11 (01) : 90 - 92
  • [5] IDENTIFICATION OF THE NEUROFIBROMATOSIS TYPE-1 GENE (NF1) - A NEW MEGAGENE
    DREYFUS, JC
    M S-MEDECINE SCIENCES, 1990, 6 (08): : 815 - 816
  • [6] AN ALU POLYMORPHISM INTRAGENIC TO THE NEUROFIBROMATOSIS TYPE-1 GENE (NF1)
    XU, GF
    NELSON, L
    OCONNELL, P
    WHITE, R
    NUCLEIC ACIDS RESEARCH, 1991, 19 (13) : 3764 - 3764
  • [7] LINKAGE ANALYSIS IN NEUROFIBROMATOSIS TYPE-1 (NF1)
    MATHEW, CGP
    THORPE, K
    WALLIS, C
    SLATER, C
    PONDER, BAJ
    JOURNAL OF MEDICAL GENETICS, 1988, 25 (09) : 645 - 645
  • [8] MOLECULAR-BASIS OF NEUROFIBROMATOSIS TYPE-1 (NF1) - MUTATION ANALYSIS AND POLYMORPHISMS IN THE NF1 GENE
    UPADHYAYA, M
    SHAW, DJ
    HARPER, PS
    HUMAN MUTATION, 1994, 4 (02) : 83 - 101
  • [9] TISSUE-SPECIFIC ALTERNATIVE SPLICING OF NEUROFIBROMATOSIS-1 (NF1) MESSENGER-RNA
    DANGLOT, G
    TEINTURIER, C
    DUVERGER, A
    BERNHEIM, A
    BIOMEDICINE & PHARMACOTHERAPY, 1994, 48 (8-9) : 365 - 372
  • [10] Mosaic Type-1 NF1 Microdeletions as a Cause of Both Generalized and Segmental Neurofibromatosis Type-1 (NF1)
    Messiaen, Ludwine
    Vogt, Julia
    Bengesser, Kathrin
    Fu, Chuanhua
    Mikhail, Fady
    Serra, Eduard
    Garcia-Linares, Carles
    Cooper, David N.
    Lazaro, Conxi
    Kehrer-Sawatzki, Hildegard
    HUMAN MUTATION, 2011, 32 (02) : 213 - 219